Justin Taylor Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine Biography Publications Institution JoVE Articles Justin Taylor has not added a biography. If you are Justin Taylor and would like to personalize this page please email our Author Liaison for assistance. Publications Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era Cancers. Mar, 2023 | Pubmed ID: 36980742 Current Landscape of Translational and Clinical Research in Myelodysplastic Syndromes/neoplasms (MDS): Proceedings from the 1 International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS) Blood Reviews. Mar, 2023 | Pubmed ID: 36934059 Trying to OutRun-DIC in KMT2Ar AML: It's Tricky Cancer. Mar, 2023 | Pubmed ID: 36892942 Targeted Therapy Development in Acute Myeloid Leukemia Biomedicines. Feb, 2023 | Pubmed ID: 36831175 Protein Biomarkers for Response to XPO1 Inhibition in Haematologic Malignancies Journal of Cellular and Molecular Medicine. Feb, 2023 | Pubmed ID: 36722323 Therapy-selected Clonal Hematopoiesis and Its Role in Myeloid Neoplasms Leukemia Research. Mar, 2023 | Pubmed ID: 36696829 Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures Blood. Jan, 2023 | Pubmed ID: 36626250 North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need Blood. Feb, 2023 | Pubmed ID: 36399715 Differences in Classification Schemata for Myelodysplastic/myeloproliferative Overlap Neoplasms Leukemia. Dec, 2022 | Pubmed ID: 36335264 Finding Consistency in Classifications of Myeloid Neoplasms: a Perspective on Behalf of the International Workshop for Myelodysplastic Syndromes Leukemia. Dec, 2022 | Pubmed ID: 36266326 Combination Venetoclax and Selinexor Effective in Relapsed Refractory Multiple Myeloma with Translocation T(11;14) NPJ Precision Oncology. Oct, 2022 | Pubmed ID: 36261486 An Agenda to Advance Research in MDS: A TOP 10 Priority List from the First International Workshop in MDS (iwMDS) Blood Advances. Oct, 2022 | Pubmed ID: 36260702 Diagnosis and Treatment of Myelodysplastic Syndromes: A Review JAMA. Sep, 2022 | Pubmed ID: 36066514 Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation Cancer Discovery. Oct, 2022 | Pubmed ID: 35904492 Splicing Dysregulation in Human Hematologic Malignancies: Beyond Splicing Mutations Trends in Immunology. Aug, 2022 | Pubmed ID: 35850914 Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors The New England Journal of Medicine. Feb, 2022 | Pubmed ID: 35196427 Hairy Cell Leukemia Masquerading As CD5+ Lymphoproliferative Disease: The Importance of V600E Testing in Diagnosis and Treatment JCO Precision Oncology. 2021 | Pubmed ID: 34250418 Divergent Clonal Evolution of Blastic Plasmacytoid Dendritic Cell Neoplasm and Chronic Myelomonocytic Leukemia from a Shared TET2-mutated Origin Leukemia. Nov, 2021 | Pubmed ID: 33833384 Azacitidine Maintenance After Allogeneic Hematopoietic Cell Transplantation for MDS and AML Blood Advances. Mar, 2021 | Pubmed ID: 33755090 Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development Cancers. Nov, 2020 | Pubmed ID: 33139625 Safety and Activity of Selinexor in Patients with Myelodysplastic Syndromes or Oligoblastic Acute Myeloid Leukaemia Refractory to Hypomethylating Agents: a Single-centre, Single-arm, Phase 2 Trial The Lancet. Haematology. Aug, 2020 | Pubmed ID: 32735836 Single-cell Genomics Reveals the Genetic and Molecular Bases for Escape from Mutational Epistasis in Myeloid Neoplasms Blood. Sep, 2020 | Pubmed ID: 32640014 Oncogenic TRK Fusions Are Amenable to Inhibition in Hematologic Malignancies The Journal of Clinical Investigation. 08, 2018 | Pubmed ID: 29920189 Sex-Biased Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis Cancer Discovery. | Pubmed ID: 34615655 Minor Intron Retention Drives Clonal Hematopoietic Disorders and Diverse Cancer Predisposition Nature Genetics. | Pubmed ID: 33846634 A Moving Target: Inactivating BTK Mutations As Drivers of Follicular Lymphoma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. | Pubmed ID: 33579791 Germ Cell Tumors and Associated Hematologic Malignancies Evolve from a Common Shared Precursor The Journal of Clinical Investigation. | Pubmed ID: 32897884 Preparation of Cytoplasmic and Nuclear Long RNAs from Primary and Cultured Cells Jacob Jahn1, Sana Chaudhry1, Maurizio Affer1, Alejandro Pardo1, Gabriel Pardo1, Justin Taylor1 1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine JoVE 64199 Ricerca sul cancro
Preparation of Cytoplasmic and Nuclear Long RNAs from Primary and Cultured Cells Jacob Jahn1, Sana Chaudhry1, Maurizio Affer1, Alejandro Pardo1, Gabriel Pardo1, Justin Taylor1 1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine JoVE 64199 Ricerca sul cancro
